Idamakanti, Muralidhar, et al. “Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review”. Journal of Medical Cases, vol. 16, no. 6, June 2025, pp. 212-21, https://doi.org/10.14740/jmc5136.